Science Daily - Heart Disease
FEBRUARY 14, 2024
Women who have both migraines and a long-term history of hot flashes and/or night sweats have a slightly higher risk of heart disease and stroke, and young women who have migraines have a higher risk of later persistent menopause symptoms, according to two new papers based on a data from a long-term study of the same group of women from their young adult to middle-age years.
DAIC
FEBRUARY 14, 2024
milla1cf Wed, 02/14/2024 - 18:21 February 14, 2024 — Efemoral Medical , developer of advanced interventional bioresorbable therapies, today announced that the United States Food & Drug Administration ( FDA ) has granted its novel Efemoral Vascular Scaffold System (EVSS) Breakthrough Device status for the treatment of de novo or restenotic lesions of the infrapopliteal arteries in patients with Chronic Limb Threatening Ischemia (CLTI).
Dr. Smith's ECG Blog
FEBRUARY 14, 2024
A 41-year-old male who presents to the emergency department with chest pain. Patient reports approximately 2 hours prior to arrival he developed a sharp chest pain that radiates into his left arm and left lower leg. Describes the radiating pain as numbness/tingling. No shortness of breath. No recent travel. No cough. No cardiac history. Here is his ECG: He had a previous ECG on file, from many years prior: What do you think?
DAIC
FEBRUARY 14, 2024
milla1cf Wed, 02/14/2024 - 18:53 February 14, 2024 — The American College of Cardiology ’s newest registry offers data-driven insights on cardiac procedures performed in the ambulatory surgery setting through its first-of-its-kind dashboard. The number of cardiac procedures being performed in ambulatory surgery centers has grown significantly in the last decade, leading ACC’s NCDR to create the CV ASC Registry Suite to fit into the established workflow and allow these facilities to measure and
Science Daily - Heart Disease
FEBRUARY 14, 2024
A groundbreaking scientific study has unveiled a remarkable discovery that may have far-reaching implications for the treatment of heart disease. The implications are immense offering glimpses of a future where heart disease may no longer be an irreversible condition but a challenge that can be overcome through medical intervention. The potential for developing novel therapies that leverage the body's innate regenerative capacity holds great promise for millions of individuals affected by heart
DAIC
FEBRUARY 14, 2024
The replacement of regular salt with a salt substitute can reduce incidences of hypertension, or high blood pressure, in older adults without increasing their risk of low blood pressure episodes, according to a study published in the Feb. 2024 issue of the Journal of the American College of Cardiology (JACC). Image courtesy: Getty Images christine.book Wed, 02/14/2024 - 09:54 February 14, 2024 — The replacement of regular salt with a salt substitute can reduce incidences of hypertension, or hig
Cardiovascular Diabetology
FEBRUARY 14, 2024
Angiogenin, an enzyme belonging to the ribonucleases A superfamily, plays an important role in vascular biology. Here, we sought to study the association of plasma angiogenin and major adverse cardiovascular e.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Physiologically Speaking
FEBRUARY 14, 2024
Cardiovascular diseases (CVDs) are the leading cause of preventable death in the world. Age is the leading risk factor for developing CVD, but physical inactivity, air pollution, and poor dietary habits are also major contributors. It’s a sobering idea that the thing that’s killing the most people is the result of modifiable lifestyle habits.
HCPLive
FEBRUARY 14, 2024
Patients with both rheumatoid arthritis and depression have an increased risk of mortality by more than 2 times than patients with RA but no depression, according to a new study.
Medical Xpress - Cardiology
FEBRUARY 14, 2024
A unique Finnish study has investigated the link between growth conditions in the womb and cardiovascular disease in adulthood. The results highlight the importance of shared genetic factors between mother and child.
HCPLive
FEBRUARY 14, 2024
A Mendelian randomization analysis provided new insights into the relationship between inflammatory cytokines and ankylosing spondylitis, rheumatoid arthritis, and psoriatic arthritis.
Medical Xpress - Cardiology
FEBRUARY 14, 2024
Taking an anticoagulant, or blood-thinning medication, can increase one's risk of—or exacerbate—a brain bleed, also known as a brain hemorrhage, which is the deadliest type of stroke. Now, new research finds that faster treatment for these patients is associated with a greater likelihood of survival.
HCPLive
FEBRUARY 14, 2024
The approval provides patients with the first-ever treatment option for severe frostbite to prevent the amputation of fingers or toes.
Medical Xpress - Cardiology
FEBRUARY 14, 2024
Switching from an unhealthy diet and sedentary lifestyle to healthy eating and exercise can be daunting. In this expert alert, Juan Cardenas Rosales, M.D., an internal medicine physician and medical director of the international medicine practice at Mayo Clinic in Jacksonville, Florida, shares small steps and one big one that can lead to a heart-healthy life.
HCPLive
FEBRUARY 14, 2024
The findings of this post-hoc analysis suggest a need for follow-up studies assessing and comparing JAK inhibition impact on the development of enthesitis.
Frontiers in Cardiovascular Medicine
FEBRUARY 14, 2024
Background The impact of early rhythm control (ERC) combined with healthy lifestyle (HLS) on the risk of ischemic stroke in elderly patients with atrial fibrillation (AF) remains unaddressed. Objective To evaluate the impact of combined ERC and HLS on the risk of stroke in elderly patients with new-onset AF. Methods Using the Korean National Health Insurance Service database, we included patients aged ≥75 years with new-onset AF from January 2009 to December 2016 ( n = 41,315).
Science Daily - Heart Disease
FEBRUARY 14, 2024
Researchers discovered why ventricular assist devices (VADs) used to support the left ventricle of cardiogenic shock patients can induce right ventricle dysfunction. They also developed a test that doctors could use to determine whether this dysfunction will occur.
HeartRhythm
FEBRUARY 14, 2024
Cardiac resynchronization therapy (CRT) is typically attempted with biventricular pacing. One-third of patients are non-responders. Left bundle branch area pacing (LBBAP) has been evaluated as an alternative means.
The New England Journal of Medicine
FEBRUARY 14, 2024
This feature about a man who has had a spontaneous pneumothorax offers a case vignette accompanied by two essays, one supporting insertion of a chest tube and the other recommending following the patient closely as an outpatient.
Medical Xpress - Cardiology
FEBRUARY 14, 2024
In Mexico City, researchers at the Instituto Nacional de Cardiología Ignacio Chávez have studied genetic underpinnings of one of the most pressing public health challenges of our times: cardiovascular disease (CVD).
Journal of the American Heart Association
FEBRUARY 14, 2024
Journal of the American Heart Association, Ahead of Print. As the older adult population expands, an increasing number of patients affected by geriatric syndromes are seen by cardiovascular clinicians. One such syndrome that has been associated with poor outcomes is cognitive frailty: the simultaneous presence of cognitive impairment, without evidence of dementia, and physical frailty, which results in decreased cognitive reserve.
Medical Xpress - Cardiology
FEBRUARY 14, 2024
Every year, around 50,000 people in the United States experience cardiogenic shock—a life-threatening condition, usually caused by a severe heart attack, in which the heart can't pump enough blood for the body's needs.
HCPLive
FEBRUARY 14, 2024
A Finnish study finds elevated cardiovascular risk in rheumatic diseases peaks within a year of diagnosis, emphasizing the need for early management strategies.
Frontiers in Cardiovascular Medicine
FEBRUARY 14, 2024
Objective Randomized controlled trials demonstrate the effectiveness of expectation-focused interventions in improving recovery outcomes following cardiac surgery. For dissemination in routine health care, it is important to capture the perspective of affected individuals. This qualitative study explores the perceived benefits and intervention-specific needs of patients who received expectation-focused intervention in the context of heart valve surgery.
American College of Cardiology
FEBRUARY 14, 2024
The goal of the ARCADIA trial was to determine whether apixaban reduces the risk of recurrent stroke compared with placebo in patients with cryptogenic ischemic stroke and evidence of atrial cardiopathy but without atrial fibrillation (AF).
Frontiers in Cardiovascular Medicine
FEBRUARY 14, 2024
Background Pulmonary embolism is a condition of right cardiac dysfunction due to pulmonary circulation obstruction. Malignant tumor-induced pulmonary embolism, which has a poor therapeutic outcome and a significant impact on hemodynamics, is the cause of sudden death in patients with malignant tumors. Case description A 38-year-old female patient, who had a medical history of right renal hamartoma, and right renal space-occupying lesion, was admitted to the hospital.
Med Page Today
FEBRUARY 14, 2024
(MedPage Today) -- FDA advisors were nearly unanimous in backing the TriClip G4 transcatheter edge-to-edge repair (TEER) device as a treatment for severe tricuspid regurgitation (TR). During an advisory committee meeting on Tuesday, the FDA's.
Journal of the American Heart Association
FEBRUARY 14, 2024
Journal of the American Heart Association, Ahead of Print. BackgroundDistal transradial access (dTRA) is an alternative to conventional forearm transradial access (fTRA) for coronary angiography (CAG). Differences in healing of the radial artery (RA) in the forearm have not been evaluated between these 2 access strategies. We sought to compare the mean difference in forearm RA intimal‐medial thickening (IMT) in patients randomized to dTRA versus fTRA.Methods and ResultsIn this single‐center rand
American College of Cardiology
FEBRUARY 14, 2024
The risk of atherosclerotic cardiovascular disease (ASCVD) is approximately twofold higher for South Asian (SA) adults than for adults from other racial and ethnic groups. Type 2 diabetes mellitus (T2DM) is a highly prevalent risk factor that likely contributes to this disparity.
HCPLive
FEBRUARY 14, 2024
After adjusting for risk factors, patients in the > 50 nmol/L pre-methotrexate initiation group exhibited a 28% reduced risk of mortality when compared with those in the ≤ 50 nmol/L group
CardiacWire
FEBRUARY 14, 2024
The FDA expert advisory panel votes are in , and they’re pointing in an overwhelmingly positive direction for Abbott’s TriClip tricuspid edge-to-edge repair (TEER) treatment. The TriClip G4 is intended to treat tricuspid regurgitation by clipping together a portion of a patient’s tricuspid valve leaflets to keep blood from leaking from the right ventricle into the atrium.
HCPLive
FEBRUARY 14, 2024
In a new study, cross-sectional analyses showed each 1-year increase in age-adjusted biological age was linked to a 1% - 10% increase in the risk of rheumatoid arthritis.
Journal of Cardiothoracic Surgery
FEBRUARY 14, 2024
Ulinastatin, an anti-inflammatory and antioxidant trypsin inhibitor, has shown potential in mitigating acute kidney injury (AKI) and reducing serum creatinine levels after various surgeries. This retrospective.
HCPLive
FEBRUARY 14, 2024
FDA advisory committee votes 13-1 that the benefits outweigh the risk of use for Abbott's TriClip for tricuspid regurgitation, pending FDA decision expected in 2024.
Cardiovascular Diabetology
FEBRUARY 14, 2024
We assessed the efficacy and safety of enavogliflozin (0.3 mg), a newly developed SGLT-2 inhibitor, in patients with type 2 diabetes mellitus based on kidney function via pooled analysis of two 24-week, random.
HCPLive
FEBRUARY 14, 2024
In addition to the newly-accepted BLA in the US, the European Medicines Agency also accepted the drug’s Marketing Authorization Application for both conditions.
Cardiovascular Diabetology
FEBRUARY 14, 2024
The 2022 Canadian Cardiovascular Society (CCS) cardiorenal guideline provided clinical recommendations on sodium-glucose co-transport 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1R.
Expert insights. Personalized for you.
116 
Let's personalize your content